Factors Contributing to Readmission of Heart Failure Patients to Emergency Departments and Prospe… (NCT07385404) | Clinical Trial Compass
CompletedNot Applicable
Factors Contributing to Readmission of Heart Failure Patients to Emergency Departments and Prospects for Improvement
France58 participantsStarted 2025-01-01
Plain-language summary
Heart failure (HF) represents a major public health challenge due to its increasing prevalence and significant impact on healthcare systems.
The burden of frequent readmissions leads to increased healthcare costs, deterioration in the quality of care, and reduced availability of hospital resources for new patients. It is therefore essential to optimize the management of patients with heart failure from their first visit to the emergency department in order to improve their prognosis and reduce the risk of rehospitalization.
In this context, this study aims to identify the key factors associated with early readmissions (\< 30 days) and to propose strategies to improve patient management and follow-up after discharge from hospital.
Who can participate
Age range
18 Years – 100 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged 18 years or older, admitted to the emergency department for confirmed acute heart failure. Hospitalization following admission to the emergency department, with at least one documented post-hospitalization follow-up visit.
Exclusion Criteria:
* Patients under the age of 18 with a primary diagnosis unrelated to heart failure after analysis of their medical records. Patients in palliative care receiving only comfort treatment. No documented post-hospitalization follow-up. Patients who object to the use of their medical data for research purposes.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.